Arcturus Therapeutics Holdings (ARCT) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -89.2% | 3.46% | -10.7% | -33.6% | -30.7% | -41.1% | ||
| Changes by years, y/y, % | -71pp | +93pp | -14pp | -23pp | +3pp | +11.1% | |||
Arcturus Therapeutics Holdings. ROE, %
Arcturus Therapeutics Holdings. ROE, changes, pp
Arcturus Therapeutics Holdings (ARCT) ROE US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROE, % | ? | -29.2% | -26.0% | -29.7% | -30.7% | -41.1% | -41.1% | |
| Changes by years, y/y, % | +11pp | +2pp | -6pp | +3pp | -12pp | |||
| Changes by quarters, q/q, % | +4pp | +3pp | -4pp | -1pp | -10pp | |||